ADMA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 6.00%

Insider Buying (Last 12 Months): $579,800.00

Insider Selling (Last 12 Months): $13,802,343.49

ADMA Biologics Insider Trading History Chart

ADMA Biologics Share Price & Price History

^$6.27

▲ +0.07 (1.13%)

As of 04/19/2024 01:00 AM ET

Days: 30 | 90 | 365

SHOCKING Crypto Leak…

From Crypto 101 Media | Ad

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

ADMA Biologics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/18/2024	Steve Elms	Director	Sell	49,887	$6.01	$299,820.87	2,527,500
3/15/2024	Steve Elms	Director	Sell	183,008	$6.01	$1,099,878.08	2,577,387
3/13/2024	Steve Elms	Director	Sell	407,000	$6.21	$2,527,470.00	3,208,671
8/30/2023	Jerrold B Grossman	Director	Buy	130,000	$3.71	$482,300.00	443,265
8/24/2023	Young Kwon	Director	Buy	25,000	$3.90	$97,500.00	277,401
8/22/2023	Bryant Fong	Director	Sell	1,433,304	$3.87	$5,546,886.48	59,901
8/18/2023	Adam S. Grossman	CEO	Sell	250,000	$4.15	$1,037,500.00	2,273,085
8/15/2023	Adam S. Grossman	CEO	Sell	510,469	$4.54	$2,317,529.26	4,113,075
8/15/2023	Brian Lenz	CFO	Sell	211,578	$4.60	$973,258.80	782,013
12/9/2022	Adam S. Grossman	CEO	Buy	14,983	$2.86	$42,851.38	2,203,708
12/9/2022	Brian Lenz	CFO	Buy	6,993	$2.86	$19,999.98	1,034,825
10/25/2021	Adam S. Grossman	CEO	Buy	250,000	$1.00	$250,000.00
10/25/2021	Brian Lenz	CFO	Buy	30,000	$1.00	$30,000.00
10/25/2021	Young Kwon	Director	Buy	100,000	$1.00	$100,000.00
9/29/2021	Perceptive Advisors Llc	Major Shareholder	Sell	82,505	$1.16	$95,705.80
9/27/2021	Perceptive Advisors Llc	Major Shareholder	Sell	250,000	$1.23	$307,500.00
9/23/2021	Perceptive Advisors Llc	Major Shareholder	Sell	780,000	$1.27	$990,600.00
8/19/2021	Perceptive Advisors Llc	Major Shareholder	Sell	350,352	$1.24	$434,436.48
8/17/2021	Perceptive Advisors Llc	Major Shareholder	Sell	879,092	$1.35	$1,186,774.20

SHOCKING Crypto Leak…

From Crypto 101 Media | Ad

Claim your free seat by clicking here now.

SEC Filings (Institutional Ownership Changes) for ADMA Biologics (NASDAQ:ADMA)

75.68% of ADMA Biologics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

ADMA Biologics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/19/2024	Mesirow Financial Investment Management Inc.	60,420	$0.40M	2.0%	-23.1%	0.026%
4/18/2024	Allspring Global Investments Holdings LLC	252,602	$1.67M	0.0%	+3.0%	0.111%
4/16/2024	Viewpoint Capital Management LLC	15,416	$0.10M	0.1%	+18.6%	0.007%
4/10/2024	EWG Elevate Inc.	100,000	$0.66M	0.3%	+100.0%	0.044%
4/5/2024	First Hawaiian Bank	122,015	$0.81M	0.0%	-22.1%	0.053%
4/5/2024	Prism Advisors Inc.	19,404	$0.13M	0.0%	N/A	0.009%
3/11/2024	Vanguard Group Inc.	12,891,875	$58.27M	0.0%	+0.9%	5.649%
3/5/2024	Wellington Management Group LLP	213,985	$0.97M	0.0%	N/A	0.095%
3/1/2024	Goldman Sachs Group Inc.	1,732,391	$7.83M	0.0%	-22.9%	0.767%
2/26/2024	Perceptive Advisors LLC	6,433,369	$29.08M	0.7%	-7.9%	2.847%
2/16/2024	Price T Rowe Associates Inc. MD	53,474	$0.24M	0.0%	+11.5%	0.024%
2/16/2024	Spouting Rock Asset Management LLC	18,399	$83K	0.0%	N/A	0.008%
2/16/2024	GSA Capital Partners LLP	16,714	$76K	0.0%	-93.1%	0.007%
2/15/2024	Townsquare Capital LLC	33,280	$0.15M	0.0%	N/A	0.015%
2/15/2024	Virtus ETF Advisers LLC	80,743	$0.37M	0.2%	+3.2%	0.036%
2/15/2024	Virtus Investment Advisers Inc.	157,268	$0.71M	0.5%	+115.7%	0.070%
2/15/2024	Legal & General Group Plc	181,381	$0.82M	0.0%	+2.8%	0.080%
2/15/2024	Barclays PLC	580,738	$2.63M	0.0%	+44.3%	0.257%
2/15/2024	Vanguard Group Inc.	12,891,875	$58.27M	0.0%	+0.9%	5.705%
2/15/2024	Velan Capital Investment Management LP	2,136,100	$9.66M	5.6%	+23.0%	0.945%
2/15/2024	Nuveen Asset Management LLC	11,355,477	$51.33M	0.0%	+6.3%	5.025%
2/15/2024	Oberweis Asset Management Inc.	2,710,700	$12.25M	1.1%	+30.4%	1.200%
2/15/2024	Occudo Quantitative Strategies LP	198,821	$0.90M	0.1%	N/A	0.088%
2/15/2024	Price T Rowe Associates Inc. MD	53,474	$0.24M	0.0%	+11.5%	0.024%
2/15/2024	Profund Advisors LLC	91,073	$0.41M	0.0%	-15.0%	0.040%
2/15/2024	Gotham Asset Management LLC	69,589	$0.32M	0.0%	-8.0%	0.031%
2/15/2024	Bayesian Capital Management LP	57,915	$0.26M	0.0%	-23.9%	0.026%
2/14/2024	Royal Bank of Canada	59,262	$0.27M	0.0%	+91.7%	0.026%
2/14/2024	Point72 Asset Management L.P.	244,513	$1.11M	0.0%	N/A	0.108%
2/14/2024	Cubist Systematic Strategies LLC	230,931	$1.04M	0.0%	-23.2%	0.102%
2/14/2024	Caxton Associates LP	19,693	$89K	0.0%	N/A	0.009%
2/14/2024	Balyasny Asset Management L.P.	32,211	$0.15M	0.0%	N/A	0.014%
2/14/2024	Sei Investments Co.	142,556	$0.64M	0.0%	+49.4%	0.063%
2/13/2024	Stonepine Capital Management LLC	9,222,617	$41.69M	18.0%	+1.3%	4.081%
2/13/2024	Northern Trust Corp	2,198,034	$9.94M	0.0%	+0.7%	0.973%
2/13/2024	Oppenheimer & Co. Inc.	121,936	$0.55M	0.0%	+4.1%	0.054%
2/13/2024	Tower Research Capital LLC TRC	29,534	$0.13M	0.0%	+231.8%	0.013%
2/13/2024	Goldman Sachs Group Inc.	1,732,391	$7.83M	0.0%	-22.9%	0.767%
2/13/2024	CIBC Private Wealth Group LLC	29,463	$0.13M	0.0%	+28.2%	0.013%
2/13/2024	Rafferty Asset Management LLC	544,349	$2.46M	0.0%	-13.0%	0.241%
2/13/2024	Campbell & CO Investment Adviser LLC	143,424	$0.65M	0.1%	+19.2%	0.063%
2/13/2024	California State Teachers Retirement System	225,381	$1.02M	0.0%	+0.9%	0.100%
2/12/2024	Alberta Investment Management Corp	460,774	$2.08M	0.0%	+32.4%	0.204%
2/12/2024	Eagle Asset Management Inc.	25,957	$0.12M	0.0%	+20.2%	0.011%
2/12/2024	Hsbc Holdings PLC	33,469	$0.15M	0.0%	+28.2%	0.015%
2/9/2024	Oxford Asset Management LLP	18,330	$83K	0.1%	N/A	0.008%
2/9/2024	UBS Group AG	498,299	$2.25M	0.0%	+118.4%	0.221%
2/7/2024	Principal Financial Group Inc.	158,634	$0.72M	0.0%	+17.7%	0.070%
2/7/2024	Dimensional Fund Advisors LP	3,491,061	$15.78M	0.0%	+19.2%	1.545%
2/7/2024	Jump Financial LLC	253,712	$1.15M	0.0%	-2.6%	0.112%
2/7/2024	BNP Paribas Financial Markets	290,605	$1.31M	0.0%	+49.8%	0.129%
2/7/2024	Teacher Retirement System of Texas	48,815	$0.22M	0.0%	-14.1%	0.022%
2/7/2024	E Fund Management Co. Ltd.	29,060	$0.13M	0.0%	-9.6%	0.013%
2/6/2024	Charles Schwab Investment Management Inc.	1,636,703	$7.40M	0.0%	+1.7%	0.724%
2/6/2024	AJOVista LLC	17,018	$77K	0.1%	N/A	0.008%
2/6/2024	Amalgamated Bank	23,790	$0.11M	0.0%	-7.5%	0.011%
2/6/2024	Swiss National Bank	421,100	$1.90M	0.0%	-4.3%	0.186%
2/5/2024	Victory Capital Management Inc.	29,192	$0.13M	0.0%	+23.0%	0.013%
2/5/2024	Intrust Bank NA	24,221	$0.11M	0.0%	+70.2%	0.011%
2/5/2024	Russell Investments Group Ltd.	613,032	$2.77M	0.0%	+62.7%	0.271%
2/2/2024	Bailard Inc.	24,400	$0.11M	0.0%	N/A	0.011%
2/1/2024	New York State Common Retirement Fund	86,652	$0.39M	0.0%	+38.4%	0.038%
1/31/2024	Calamos Advisors LLC	250,185	$1.13M	0.0%	+122.5%	0.111%
1/31/2024	Federated Hermes Inc.	807,012	$3.65M	0.0%	+4.4%	0.357%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	56,706	$0.26M	0.0%	+20.8%	0.025%
1/26/2024	Peregrine Capital Management LLC	882,983	$3.99M	0.1%	N/A	0.391%
1/25/2024	Allspring Global Investments Holdings LLC	245,139	$1.11M	0.0%	-12.3%	0.108%
1/24/2024	DekaBank Deutsche Girozentrale	236,178	$1.07M	0.0%	+1,359.9%	0.105%
1/24/2024	Arizona State Retirement System	59,728	$0.27M	0.0%	+4.9%	0.026%
1/24/2024	China Universal Asset Management Co. Ltd.	26,142	$0.12M	0.0%	+353.5%	0.012%
1/17/2024	PFG Investments LLC	43,000	$0.19M	0.0%	-23.2%	0.019%
1/17/2024	Assenagon Asset Management S.A.	3,945,225	$17.83M	0.0%	-21.6%	1.746%
1/16/2024	Raymond James Financial Services Advisors Inc.	232,250	$1.05M	0.0%	-6.5%	0.103%
1/16/2024	Raymond James & Associates	249,296	$1.13M	0.0%	+2.3%	0.110%
1/12/2024	SG Americas Securities LLC	93,236	$0.42M	0.0%	+417.3%	0.041%
1/11/2024	Mesirow Financial Investment Management Inc.	78,605	$0.38M	1.5%	+8.2%	0.035%
1/9/2024	EWG Elevate Inc.	50,000	$0.23M	0.1%	+100.0%	0.022%
1/9/2024	First Hawaiian Bank	156,621	$0.71M	0.0%	-2.2%	0.069%
12/18/2023	Vanguard Group Inc.	12,781,695	$45.76M	0.0%	+2.7%	5.656%
12/6/2023	Citigroup Inc.	276,700	$0.99M	0.0%	-3.8%	0.122%
11/30/2023	American Century Companies Inc.	4,892,123	$17.51M	0.0%	+20.8%	2.165%
11/24/2023	Deutsche Bank AG	107,934	$0.39M	0.0%	+29.7%	0.048%
11/22/2023	Graham Capital Management L.P.	28,205	$0.10M	0.0%	-27.6%	0.012%
11/21/2023	Walleye Trading LLC	30,776	$0.11M	0.0%	N/A	0.014%
11/21/2023	Walleye Capital LLC	926,745	$3.32M	0.0%	N/A	0.410%
11/16/2023	GTS Securities LLC	10,571	$38K	0.0%	N/A	0.005%
11/16/2023	Tudor Investment Corp Et Al	173,818	$0.62M	0.0%	+544.9%	0.077%
11/16/2023	Morgan Stanley	5,239,371	$18.76M	0.0%	+39.0%	2.330%
11/15/2023	GSA Capital Partners LLP	242,284	$0.87M	0.1%	+87.7%	0.108%
11/15/2023	Kennedy Capital Management LLC	791,047	$2.83M	0.1%	-28.7%	0.352%
11/15/2023	Legal & General Group Plc	176,505	$0.63M	0.0%	+9.2%	0.078%
11/15/2023	Adage Capital Partners GP L.L.C.	3,767,558	$13.49M	0.0%	+15.1%	1.675%
11/15/2023	Ameriprise Financial Inc.	419,340	$1.50M	0.0%	+4.1%	0.186%
11/15/2023	Alberta Investment Management Corp	347,943	$1.25M	0.0%	-2.0%	0.155%
11/15/2023	AQR Capital Management LLC	542,043	$1.94M	0.0%	+20.0%	0.241%
11/14/2023	Lazard Asset Management LLC	103,751	$0.37M	0.0%	+21.4%	0.046%
11/14/2023	AWM Investment Company Inc.	5,999,872	$21.48M	3.2%	-0.3%	2.668%
11/14/2023	Gotham Asset Management LLC	75,619	$0.27M	0.0%	+23.9%	0.034%
11/14/2023	Fred Alger Management LLC	956,010	$3.42M	0.0%	-65.6%	0.425%
11/14/2023	Sherbrooke Park Advisers LLC	37,944	$0.14M	0.0%	N/A	0.017%

Data available starting January 2016

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

Today's Range

Now: $6.27

$6.10

$6.29

50 Day Range

MA: $5.96

$5.15

$6.74

52 Week Range

Now: $6.27

$3.06

$6.76

Volume

3,411,848 shs

Average Volume

2,659,694 shs

Market Capitalization

$1.43 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.46

Who are the company insiders with the largest holdings of ADMA Biologics?: ADMA Biologics' top insider investors include:
Adam S Grossman (CEO)
Steve Elms (Director)
Brian Lenz (CFO)
Jerrold B Grossman (Director)
Young Kwon (Director)
Bryant Fong (Director)
Learn More about top insider investors at ADMA Biologics.
Who are the major institutional investors of ADMA Biologics?: ADMA Biologics' top institutional shareholders include:
Allspring Global Investments Holdings LLC — 0.11%
First Hawaiian Bank — 0.05%
EWG Elevate Inc. — 0.04%
Mesirow Financial Investment Management Inc. — 0.03%
Prism Advisors Inc. — 0.01%
Viewpoint Capital Management LLC — 0.01%
Learn More about top institutional investors of ADMA Biologics stock.
Which institutional investors are selling ADMA Biologics stock?: Within the last quarter, ADMA stock was sold by these institutional investors:
First Hawaiian Bank
Mesirow Financial Investment Management Inc.
Within the previous year, company insiders that have sold ADMA Biologics company stock include:
Adam S Grossman (CEO)
Steve Elms (Director)
Brian Lenz (CFO)
Jerrold B Grossman (Director)
Learn More investors selling ADMA Biologics stock.
Which institutional investors are buying ADMA Biologics stock?: Within the previous quarter, ADMA stock was acquired by institutional investors including:
EWG Elevate Inc.
Prism Advisors Inc.
Allspring Global Investments Holdings LLC
Viewpoint Capital Management LLC
During the previous year, these company insiders have bought ADMA Biologics stock:
Adam S Grossman (CEO)
Steve Elms (Director)
Brian Lenz (CFO)
Jerrold B Grossman (Director)
Learn More investors buying ADMA Biologics stock.